Evolent Health closed at $4.54 on Nov 5, down 5.42%, 30.0% below its 52-week closing high. Volume of 3.5M shares was 1.95× its 20-day average (above normal).
Split-adjusted performance: +9.7% over one month, +6.3% over six months, -30.0% over one year.
In the quarter ended Jun 30, 2026, revenue was $652.52M, up 46.9% from a year earlier, with a net margin of -4.3%.
Short interest was 11.9M shares at the Oct 15 settlement, down 7.8% from the prior report (11.3% of float, 5.6 days to cover).